These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2149292)

  • 21. Characterization of binding sites for two classes of calcium channel antagonists in human forebrain.
    Quirion R
    Eur J Pharmacol; 1985 Oct; 117(1):139-42. PubMed ID: 2935407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spironolactone inhibition of contraction and calcium channels in rat portal vein.
    Dacquet C; Loirand G; Mironneau C; Mironneau J; Pacaud P
    Br J Pharmacol; 1987 Nov; 92(3):535-44. PubMed ID: 3427267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tricyclic antidepressants and calcium channel blockers: interactions at the (-)-desmethoxyverapamil binding site and the serotonin transporter.
    Rehavi M; Carmi R; Weizman A
    Eur J Pharmacol; 1988 Oct; 155(1-2):1-9. PubMed ID: 2854066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel high affinity class of Ca2+ channel blockers.
    Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
    Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The binding of (+)-isradipine by guinea-pig intact atria.
    Herzig S; Lüllmann H
    Br J Pharmacol; 1989 Aug; 97(4):1246-50. PubMed ID: 2529016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marrubenol interacts with the phenylalkylamine binding site of the L-type calcium channel.
    El Bardai S; Hamaide MC; Lyoussi B; Quetin-Leclercq J; Morel N; Wibo M
    Eur J Pharmacol; 2004 May; 492(2-3):269-72. PubMed ID: 15178374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).
    Gu XH; Liu JJ; Dillon JS; Nayler WG
    Br J Pharmacol; 1989 Feb; 96(2):262-4. PubMed ID: 2538185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of (-)-desmethoxyverapamil on heart and vascular smooth muscle.
    Nawrath H; Raschack M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1090-7. PubMed ID: 3656109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3,4,5-Triiodobenzoic acid affects [3H]verapamil binding to plant and animal membrane fractions and smooth muscle contraction.
    Andrejauskas E; Hertel R; Marmé D
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1269-75. PubMed ID: 3753496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of Ca2+ channels in smooth muscle.
    Mironneau J
    Z Kardiol; 1991; 80 Suppl 7():43-6. PubMed ID: 1665262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptics of the diphenylbutylpiperidine series are potent calcium channel inhibitors.
    Galizzi JP; Fosset M; Romey G; Laduron P; Lazdunski M
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7513-7. PubMed ID: 2429309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR; Donowitz M; Weiland GA; Sharp GW
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of calcium entry blockers on calcium-dependent contractions of rat portal vein.
    Dacquet C; Mironneau C; Mironneau J
    Br J Pharmacol; 1987 Sep; 92(1):203-11. PubMed ID: 2959345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of the phenylalkylamine binding site in canine cardiac sarcolemmal membranes.
    Dumont L; Williams JS; Vaghy PL; Schwartz A
    Basic Res Cardiol; 1988; 83(4):369-75. PubMed ID: 2847707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.